X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Bangalore – The Silicon City, is now the Pharma City

Yuvraj_pawp by Yuvraj_pawp
27th February 2015
in Asia, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

“There is no second thought on the capability of the Indian pharma industry and Bangalore is gearing up to play its role as a pharma destination for the future. Companies like Biocon, Strides Arcolab and Micro Labs have exercised their strengths not just in exports of active pharmaceutical ingredients (APIs) and formulations but portray their expertise and reliability in adhering to timeline deliveries in contract research and manufacturing services. Apotex Pharmachem India, an associated company of Apotex Pharmachem Inc., Canada, has set up an integrated operation for API research and manufacturing formulations to clinical studies, committing over $ 100 million and will create over 1,000 jobs in Bengaluru,” says Dr P M Akbarali, Managing Director of the Bengaluru based Apotex Pharmachem India.

“Bangalore complements the supportive knowledge-based environment created for the growth of the pharma industry,” continues Dr Akbarali. Supply of quality students from the academic institutions could be a differential as far as sourcing the intellectual capital required to support the foundation is concerned. The technical support in solid state chemistry from research centres have chipped in the necessary inputs for Intellectual Property that could help challenge patents and give the companies an edge in the developed market of US, Europe and Japan. The advanced information technology industry too makes up for the much-needed support. Many companies from abroad setting up R&D centres in India and Bengaluru are a testimony to this recognition.

India can be known as the Pharma Powerhouse going by the industry’s maturity to meet the challenges of regulated regimes of the developed countries and provide cost competitive drugs, he said.

In a recap on the performance of Indian pharma so far, Dr Akbarali pointed out that the current scene is quite upbeat from an industry growth point of view. Today, the knowledge base is strong and the critical mass in terms of skilled personnel are making significant contributions for the growth of the sector. The presence of a dedicated US FDA office here for South Asia recognizes India’s prowess in the regulated regions.

Tags: Asia Pacific
Previous Post

GSK's new chairman Hampton to take charge in May

Next Post

Alizé Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

Alizé Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In